Condensed purine derivatives as a1 adenosine receptor...

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 487/14 (2006.01) A61K 31/505 (2006.01) A61P 9/00 (2006.01)

Patent

CA 2430508

Compounds of Formula I and II are disclosed as antagonists of subtype A1 adenosine receptors. These compounds are useful for treatment of various diseases and disorders, including systemic hypertension, renal failure, diabetes, asthma, an edematous condition, congestive heart failure, and renal dysfunction.

L'invention concerne des composés représentés par les formules I et II servant d'antagonistes des récepteurs d'adénosine de sous-type A1. Ces composés sont utilisés dans le traitement de diverses maladies et troubles, y compris l'hypertension systémique, l'insuffisance rénale, le diabète, l'asthme, un état oedémateux, l'insuffisance cardiaque congestive, et un dysfonctionnement rénal.FORMULE I FORMULE II

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Condensed purine derivatives as a1 adenosine receptor... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Condensed purine derivatives as a1 adenosine receptor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Condensed purine derivatives as a1 adenosine receptor... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1734422

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.